# A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes

> **NCT01965509** · PHASE2 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 120 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** PEX168 or placebo

## Key facts

- **NCT ID:** NCT01965509
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2013-08
- **Final completion:** 2013-10
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2013-10-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01965509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01965509, "A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01965509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*